NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
Home » whitepapers » PCT direct makes bedside diagnosis possible

Thermo Fisher Scientific - Procalcitonin for neonatal sepsis diagnosis and safe antibiotic guidance

White Paper

PCT direct makes bedside diagnosis possible

In emergency departments, unforeseeable situations are routine. Ever-more rapid and reliable results are vital, and can have exponential benefits with regard to clinical outcomes and patient management. Thermo Fisher Scientific has developed the first quantitative whole-blood point-of-care procalcitonin (PCT) test to help medical staff to make informed decisions.

Download to find out more.

Download White Paper